(ACLS) Axcelis Technologies - NASDAQ

Sector: Technology | Industry: Semiconductor Equipment & Materials | Exchange: NASDAQ (USA) | Market Cap: 5.764m USD | Total Return: 142.6% in 12m

Ion Implanters, Spare Parts, Maintenance Services, Equipment Upgrades

Total Rating 50

Safety 58

Buy Signal -0.08

Semiconductor Equipment & Materials
Industry Rotation: -9.0

Market Cap: 5.76B
Avg Turnover: 92.7M

Risk 3d forecast

Volatility71.4%

VaR 5^th Pctl11.9%

VaR vs Median1.36%

Reward TTM

Sharpe Ratio1.72

Rel. Str. IBD95.4

Rel. Str. Peer Group33.8

Character TTM

Beta2.259

Beta Downside2.079

Hurst Exponent0.381

Drawdowns 3y

Max DD78.84%

CAGR/Max DD-0.01

CAGR/Mean DD-0.02

EPS (Earnings per Share)

EPS CAGR: -15.80%
EPS Trend: -85.8%

Last SUE: 0.06
Qual. Beats: 0

Revenue

Rev. CAGR: -10.65%
Rev. Trend: -86.6%

Last SUE: 0.61
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

Confidence

Description: ACLS Axcelis Technologies

Axcelis Technologies (ACLS) specializes in the design and manufacture of ion implantation systems, a critical stage in the semiconductor fabrication process where dopants are introduced into silicon wafers to alter electrical properties. The company supports its hardware through a comprehensive aftermarket segment, providing maintenance, upgrades, and spare parts to chip manufacturers globally.

The semiconductor equipment sector is characterized by high barriers to entry due to the extreme precision and capital intensity required for ion implantation technology. As chip architectures become more complex, particularly in power electronics and image sensors, the demand for specialized high-energy and high-current implanters remains a key driver for the business model.

Investors can further evaluate these industry trends and specific company metrics on ValueRay.

Headquartered in Beverly, Massachusetts, Axcelis operates via a direct sales model across the United States, Europe, and Asia Pacific. Founded in 1978, the firm maintains a long-standing position within the Semiconductor Materials & Equipment sub-industry.

Headlines to Watch Out For

Silicon carbide power device demand fuels high-energy ion implanter revenue growth
Electric vehicle market expansion drives power semiconductor manufacturing equipment sales
Geopolitical trade restrictions impact equipment shipments to Chinese chip manufacturers
Mature process node investment cycles dictate long-term capital equipment order book
Aftermarket service and parts revenue provides recurring high-margin cash flow stability

Piotroski VR-10 (Strict) 4.5

Net Income: 100.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -2.73 > 1.0
NWC/Revenue: 86.55% < 20% (prev 95.36%; Δ -8.80% < -1%)
CFO/TA 0.07 > 3% & CFO 96.6m > Net Income 100.9m
Net Debt (-324.6m) to EBITDA (137.5m): -2.36 < 3
Current Ratio: 4.59 > 1.5 & < 3
Outstanding Shares: last quarter (31.0m) vs 12m ago -4.19% < -2%
Gross Margin: 43.61% > 18% (prev 44.61%; Δ -1.00% > 0.5%)
Asset Turnover: 62.28% > 50% (prev 71.46%; Δ -9.19% > 0%)
Interest Coverage Ratio: 22.65 > 6 (EBIT TTM 119.8m / Interest Expense TTM 5.29m)

Altman Z'' 8.63

A: 0.53 (Total Current Assets 935.7m - Total Current Liabilities 203.9m) / Total Assets 1.37b
B: 0.37 (Retained Earnings 512.8m / Total Assets 1.37b)
C: 0.09 (EBIT TTM 119.8m / Avg Total Assets 1.36b)
D: 3.17 (Book Value of Equity 1.04b / Total Liabilities 329.9m)
Altman-Z'' = 8.63 = AAA

Beneish M -2.03

DSRI: 1.11 (Receivables 161.8m/164.9m, Revenue 845.4m/958.1m)
GMI: 1.02 (GM 44.61% / 43.61%)
AQI: 2.63 (AQ_t 0.25 / AQ_t-1 0.09)
SGI: 0.88 (Revenue 845.4m / 958.1m)
TATA: 0.00 (NI 100.9m - CFO 96.6m) / TA 1.37b)
Beneish M = -2.03 (Cap -4..+1) = BB

What is the price of ACLS shares?

As of June 26, 2026, the stock is trading at USD 168.91 with a total of 538,758 shares traded. Over the past week, the price has changed by -4.49%, over one month by +2.82%, over three months by +78.95% and over the past year by +142.55%.

Current recommended Stop Loss: 138.70 (which is 17.9% or 2.4 ATR below the current price).

Is ACLS a buy, sell or hold?

Axcelis Technologies has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold ACLS.

StrongBuy: 2
Buy: 0
Hold: 2
Sell: 1
StrongSell: 0

What are the forecasts/targets for the ACLS price?

Analysts Target Price	161	-4.7%

Axcelis Technologies (ACLS) - Fundamental Data Overview as of 20 June 2026

Market Cap USD = 5.76b (5.76b USD * 1.0 USD.USD)
P/E Trailing = 58.2391
P/E Forward = 49.7512
P/S = 6.8172
P/B = 5.5172
P/EG = 1.4493
Revenue TTM = 845.4m USD
EBIT TTM = 119.8m USD
EBITDA TTM = 137.5m USD
Long Term Debt = 40.8m USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 1.65m USD (from shortTermDebt, last quarter)
Debt = 42.0m USD (from shortLongTermDebtTotal, last quarter) (leases 42.0m already included)
Net Debt = -324.6m USD (calculated: Debt 42.0m - CCE 366.6m)
Enterprise Value = 5.44b USD (5.76b + Debt 42.0m - CCE 366.6m)
Interest Coverage Ratio = 22.65 (Ebit TTM 119.8m / Interest Expense TTM 5.29m)
EV/FCF = 61.47x (Enterprise Value 5.44b / FCF TTM 88.5m)
FCF Yield = 1.63% (FCF TTM 88.5m / Enterprise Value 5.44b)
FCF Margin = 10.46% (FCF TTM 88.5m / Revenue TTM 845.4m)
Net Margin = 11.93% (Net Income TTM 100.9m / Revenue TTM 845.4m)
Gross Margin = 43.61% ((Revenue TTM 845.4m - Cost of Revenue TTM 476.8m) / Revenue TTM)
Gross Margin QoQ = 40.50% (prev 46.97%)
Tobins Q-Ratio = 3.96 (Enterprise Value 5.44b / Total Assets 1.37b)
Interest Expense / Debt = 12.60% (Interest Expense 5.29m / Debt 42.0m)
Taxrate = 12.88% (14.9m / 115.8m)
NOPAT = 104.3m (EBIT 119.8m * (1 - 12.88%))
Current Ratio = 4.59 (Total Current Assets 935.7m / Total Current Liabilities 203.9m)
Debt / Equity = 0.04 (Debt 42.0m / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = -2.36 (Net Debt -324.6m / EBITDA 137.5m)
Debt / FCF = -3.67 (Net Debt -324.6m / FCF TTM 88.5m)
Total Stockholder Equity = 1.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.43% (Net Income 100.9m / Total Assets 1.37b)
RoE = 9.79% (Net Income TTM 100.9m / Total Stockholder Equity 1.03b)
RoCE = 11.18% (EBIT 119.8m / Capital Employed (Equity 1.03b + L.T.Debt 40.8m))
RoIC = 9.23% (NOPAT 104.3m / Invested Capital 1.13b)
WACC = 13.91% (E(5.76b)/V(5.81b) * Re(13.93%) + D(42.0m)/V(5.81b) * Rd(12.60%) * (1-Tc(0.13)))
Discount Rate = 13.93% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -100.00 | Cagr: -2.81%
[DCF] Terminal Value 55.37% ; FCFF base≈102.2m ; Y1≈89.7m ; Y5≈72.4m
[DCF] Fair Price = 30.50 (EV 612.9m - Net Debt -324.6m = Equity 937.5m / Shares 30.7m; r=13.91% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -85.82 | EPS CAGR: -15.80% | SUE: 0.06 | # QB: 0
Revenue Correlation: -86.61 | Revenue CAGR: -10.65% | SUE: 0.61 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.89 | Chg30d=+9.61% | Revisions=+20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=1.05 | Chg30d=+5.73% | Revisions=-20% | Analysts=3
EPS current Year (2026-12-31): EPS=3.83 | Chg30d=+5.16% | Revisions=+20% | GrowthEPS=-21.5% | GrowthRev=+0.4%
EPS next Year (2027-12-31): EPS=4.64 | Chg30d=+2.75% | Revisions=-20% | GrowthEPS=+21.0% | GrowthRev=+9.4%
[Analyst] Revisions Ratio: +20%